EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A novel SaeS-targeting antivirulence antagonist screened against methicillin-resistant Staphylococcus aureus

Jiahao Yao, Duiyuan Ai, Huanhuan Duan

Frontiers in Cellular and Infection Microbiology · 08.07.2026 · 16

DOI: 10.3389/fcimb.2026.1867130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 08.07.2026. Verfasst von Jiahao Yao und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Food Science and Engineering, Gansu Agricultural University, Lanzhou, Gansu, China. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Bacterial Proteins, Anti-Bacterial Agents, Protein Kinases. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gansu Agricultural University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The SaeRS two-component system is a major virulence regulator in Staphylococcus aureus , and its sensor kinase SaeS represents a potential target for small-molecule intervention.

Methods

In this study, we constructed a library of 1,093 compounds from PubChem and carried out structure-guided virtual screening against the SaeS kinase domain. This approach identified an amide-based candidate, designated Saeamid-1. Molecular docking and molecular dynamics simulations supported stable binding of Saeamid-1 within the nucleotide-binding region of SaeS, with a docking score of -9.884 kcal/mol.

Results

The compound had only limited effects on bacterial growth. In contrast, it reduced hemolytic activity and biofilm biomass in USA300 by 65.74% and 88.77%, respectively. RT-qPCR analysis showed that Saeamid-1 reduced the expression of saeR, saeS , and the SaeRS- associated virulence gene spa .

Conclusions

Taken together, these findings identify Saeamid-1 as a promising antivirulence candidate that targets SaeS in methicillin-resistant Staphylococcus aureus and provide a basis for further development of therapeutic strategies directed against the SaeRS pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusBacterial ProteinsAnti-Bacterial AgentsProtein KinasesBiofilmsMolecular Docking SimulationVirulenceMolecular Dynamics SimulationGene Expression Regulation, BacterialMicrobial Sensitivity TestsHemolysisSmall Molecule LibrariesTranscription Factors

Stichwörter der Autor:innen

SaeRS two-component systemantivirulencecomputational modelingmethicillin-resistant Staphylococcus aureusquorum-sensing quenching

Substanzen

Bacterial ProteinsAnti-Bacterial AgentsProtein KinasesSaeS protein, Staphylococcus aureusSaeR protein, Staphylococcus aureusSmall Molecule LibrariesTranscription Factors

Autor:innen und Institutionen

  • College of Food Science and Engineering, Gansu Agricultural University, Lanzhou, Gansu, China.

Förderung

  • Gansu Agricultural University

Zitieren

APA

Yao, J., Ai, D., & Duan, H. (2026). A novel SaeS-targeting antivirulence antagonist screened against methicillin-resistant Staphylococcus aureus. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1867130

Vancouver

Yao J, Ai D, Duan H. A novel SaeS-targeting antivirulence antagonist screened against methicillin-resistant Staphylococcus aureus. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1867130

BibTeX
@article{Yao2026,
  author = {Yao, Jiahao and Ai, Duiyuan and Duan, Huanhuan},
  title = {A novel SaeS-targeting antivirulence antagonist screened against methicillin-resistant Staphylococcus aureus},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1867130}
}
Kostenlos starten →